Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis

ClinicalTrials.gov ID: NCT07265479

Public ClinicalTrials.gov record NCT07265479. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 7:05 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Vehicle-Controlled (Period 1) and Open-Label (Period 2) Phase 3 Study to Investigate the Safety and Efficacy of Tapinarof Cream, 1% in Pediatric Participants Ages 3 Months to < 24 Months With Atopic Dermatitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this global Phase 3 clinical study is to investigate the safety and efficacy of tapinarof cream, 1% in participants ages 3 months to 23 months (inclusive) with atopic dermatitis.

Study identification

NCT ID
NCT07265479
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Organon and Co
Industry
Enrollment
187 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
3 Months to 23 Months
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 28, 2025
Primary completion
Jul 31, 2027
Completion
Jul 31, 2027
Last update posted
Aug 11, 2026

2025 – 2027

United States locations

U.S. sites
36
U.S. states
24
U.S. cities
35
Facility City State ZIP Site status
AllerVie Clinical Research Birmingham Alabama 35209
Dermatology Trial Associates Bryant Arkansas 72022
Dermatology Research Associates Los Angeles California 90045
Integrative Skin Science and Research Sacramento California 95815
Allergy and Asthma Medical Group and Research Center San Diego California 92123
Clinical Trials Research Institute Thousand Oaks California 91320
Clarity Dermatology Castle Rock Colorado 80109
Skin Care Research, LLC. Boca Raton Florida 33486
APEX Clinical Trials Jacksonville Florida 32256
TruDerm Research Wellington Florida 33449
Cleaver Medical Group Dermatology, Inc Cumming Georgia 30040
Ada West Research Meridian Idaho 83646
Endeavor Health Clinical Trials Center Skokie Illinois 60077
Dawes Fretzin Clinical Research Group, LLC Indianapolis Indiana 46250
The Indiana Clinical Trials Center, PC Plainfield Indiana 46168
Equity Medical, LLC Bowling Green Kentucky 42104
Lawrence J Green, MD LLC Rockville Maryland 20850
Oakland Hills Dermatology Auburn Hills Michigan 48326
Minnesota Clinical Study Center New Brighton Minnesota 55112
SKY Integrative Medical Center Ridgeland Mississippi 39157
MediSearch Clinical Trials Saint Joseph Missouri 64506
Skin Cancer and Dermatology Institute Reno Nevada 89509
Forest Hills Dermatology Group Kew Gardens New York 11415
Bobby Buka MD, PC New York New York 10012
Equity Medical, LLC The Bronx New York 10455
The University of North Carolina Dermatology and Skin Cancer Center Chapel Hill North Carolina 27516
Dermatologists of Central States, LLC Fairborn Ohio 45324
Allergy Asthma and Clinical Research Center Oklahoma City Oklahoma 73120
Oregon Dermatology and Research Center Portland Oregon 97210
Oregon Health & Science University Portland Oregon 97239
Medical University of South Carolina Charleston South Carolina 29425
National Allergy and Asthma Research, LLC. North Charleston South Carolina 29420
The University of Texas Health Science Center at Houston Bellaire Texas 77401
Dermatology Treatment and Research Center Dallas Texas 75230
Stryde Research - Epiphany Dermatology Southlake Texas 76092
Dermatology Specialists of Spokane Spokane Washington 99202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07265479, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 11, 2026 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07265479 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →